Overview
Mia represents issuers and underwriters in issuances of equity and debt securities in public and private offerings, including registered initial public offerings and follow-on offerings in the US, high yield and investment grade debt offerings, GMTN program updates and drawdowns, private placements and restricting of debt structures and consent solicitation.
She also advises public companies on securities filings and corporate governance matters, as well as unsolicited takeovers, merger and acquisitions and pre-IPO financings.
Mia’s clients span across industries, including fintech, healthcare, technology, financial services, automotive, mining, manufacturing, real estate and education.
Having spent five years as an attorney in a leading law firm in Hong Kong, Mia brings significant APAC relationships and experience to clients as well as the perspective she gained at Credit Suisse as a secondee in Hong Kong and at HSBC as an in-house counsel in Shanghai, China.
Representative Experience
- Representation of underwriters in US$100 million initial public offering of ADSs on NASDAQ by a global online brokerage platform (closed March 2019), and representation of underwriters in the same client’s US$1.4 billion follow-on offering of ADSs on NASDAQ (closed April 2021)
- Representation of a large parcel merchandise platform in its US$36 million initial public offering of ordinary shares on NASDAQ (closed August 2022)
- Representation of underwriters in US$40 million initial public offering of ADSs on NASDAQ by a Chinese online education company (closed January 2023)
- Advising a global vaccine manufacturer listed on NASDAQ in its general corporate and compliance matters from 2021 to 2024, including advising on unsolicited tender offers
- Representation of underwriters in the US$20 billion global medium term notes program update and following drawdowns of US$6 billion multi-tranche notes issued by a Chinese multinational technology conglomerate pursuant to Rule 144A and Regulation S (closed April 2019)
- Representation of a Chinese chemical company and the parent company of Syngenta, in the offering of US$2 billion multi-currency, multi-tranche bonds and its tap issuance (closed June 2019 and March 2020)
- Advising an Indian multinational conglomerate in its US$4.5 billion acquisition financing (closed September 2022)
- Advising a NASDAQ listed company in the automation industry in its corporate governance review and unsolicited takeover matters in 2020 and 2021
- Representation of deal manager and solicitation agent in the exchange offers and consent solicitations in relation to eight outstanding notes guaranteed by a Chinese real estate developer (closed November 2021)
- Representation of underwriters in HK$985 million (US$126 million) initial public offering of a Chinese LiDAR company on the Hong Kong Stock Exchange, including an international offering in reliance of Regulation S (closed January 2024)
- Representation of a global lithium producer in its HK$13.5 billion (US$1.7 billion) H share initial public offering on the Hong Kong Stock Exchange, including an international offering in reliance of Rule 144A and Regulation S (closed July 2022)
- Representation of underwriters in the medium term note and perpetual securities program update of a Chinese multinational conglomerate in the chemicals and fertilizer industry (closed September 2022)
Education
J.D., Peking University, Law School, 2012
LL.M. University of Pennsylvania Carey Law School, 2015
Admissions
- New York, 2016
- Not Admitted in North Carolina